Transition between prediabetic and diabetic stages in an urban community in india: a decade-long retrospective cohort study

印度某城市社区糖尿病前期向糖尿病阶段转变:一项为期十年的回顾性队列研究

阅读:1

Abstract

PURPOSE: The rising prevalence of prediabetes has increased the risk of diabetes, particularly among younger populations, if timely interventions are not implemented. In India, the limited availability of cohort-based incidence studies underscores the need for retrospective analyses using hospital-based electronic medical information systems (EMIS). This study estimates the transition probabilities and duration of stay in the prediabetic state before progression to type 2 diabetes in a cohort of normoglycemic individuals. METHODS: Data from 1,670 diabetes-free individuals aged 30 years and above were extracted from a government hospital's electronic medical records spanning a 10-year period. Incidence rates of type II diabetes were calculated separately for individuals with baseline normoglycemia and prediabetes. A multistate model was employed to estimate transition probabilities between normoglycemia, prediabetes, and diabetes over time. RESULTS: The overall incidence of type II diabetes was 20.94 per 1,000 person-years, with higher rates among individuals with baseline prediabetes (41.74 vs. 15.89 per 1,000 PYs in normoglycemic individuals). The probability of progressing from prediabetes to diabetes reached ~ 30%, while normoglycemia to prediabetes reached ~ 25%. Reversion from prediabetes to normoglycemia peaked at around 60% within the first 2-3 years and later declined. Males had a higher likelihood of progressing to diabetes, whereas females showed higher prediabetic reversal. CONCLUSION: The study underscores the critical importance of early detection and timely intervention during the prediabetic phase to prevent progression to diabetes and associated complications.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。